Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Cd44 | Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses. | Journal of leukocyte biology, 2014 Sep | Antibody | CL023A |
| CD44 | Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma | Cancer Science, 2014 Jul | Antibody | SM1118F |
| CD44 | In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry | Cytometry A, 2012 Mar | Antibody | SM502F |
| CD44 | In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry | Cytometry A, 2012 Mar | Antibody | SM502PS |
| CD44 | In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry | Cytometry A, 2012 Mar | Antibody | SM502R |
| CD44 | Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells() | Cell Med, 2012 Jan | Antibody | SM502F |
| CD44 | Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells() | Cell Med, 2012 Jan | Antibody | SM502PS |
| CD44 | Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells() | Cell Med, 2012 Jan | Antibody | SM502R |
| CD44 | Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations | Stem Cells Dev., 2010 Feb | Antibody | SM502F |
| CD44 | Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations | Stem Cells Dev., 2010 Feb | Antibody | SM502PS |
| CD44 | Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations | Stem Cells Dev., 2010 Feb | Antibody | SM502R |
| CD45 | Association between gastroesophageal reflux disease and vocal fold polyps | Medicine, 2021 May | Antibody | TA807197S |
| CD45 | Combination of optimized tissue engineering bone implantation with heel-strike like mechanical loading to repair segmental bone defect in New Zealand rabbits | Cell and tissue research, 2021 May | Antibody | TA807197 |
| CD45 | Assessment of the in vivo biofunctionality of a biomimetic hybrid scaffold for osteochondral tissue regeneration | Biotechnol Bioeng, 2020 Sep | Antibody | TA807197 |
| cd45 | Ischemia Reperfusion Injury Triggers CXCL13 Release and B-Cell Recruitment After Allogenic Kidney Transplantation | Frontiers in Immunology, 2020 Aug | Antibody | SM3130P |
| CD45 | Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour | EBioMedicine, 2020 Jun | Antibody | TA807197 |
| CD45 | T-Box20 inhibits osteogenic differentiation in adipose-derived human mesenchymal stem cells: the role of T-Box20 on osteogenesis | J Biol Res (Thessalon) 2019, 2019 Dec | Antibody | TA807197 |
| CD45 | Regenerative Features of Adipose Tissue for Osteoarthritis Treatment in a Rabbit Model: Enzymatic Digestion Versus Mechanical Disruption | Int J Mol Sci, 2019 May | Antibody | TA807197 |
| CD45 | Isolation and characterization of minipig perivascular stem cells for bone tissue engineering | Mol Med Rep, 2018 Oct | Antibody | SM563R |
| CD46 | Induction of cell-cell fusion from without by human herpesvirus 6B | J. Virol., 2018 Oct | Antibody | BM4042 |
| CD46 | Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers | Oncotarget, 2016 Jun | Antibody | TA590375 |
| CD46 | Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers | Oncotarget, 2016 Jun | Antibody | TA349781 |
| CD5 | LGR5/R-Spo1/Wnt3a axis promotes stemness and aggressive phenotype in hepatoblast-like hepatocellular carcinoma cell lines. | Cellular signalling, 2022 Jan | Antibody | TA301354 |
| CD5 | Hemophagocytic lymphohistiocytosis presenting with annular erythema multiforme‑like eruptions in a patient with angioimmunoblastic T cell lymphoma: A case report | Exp Ther Med, 2018 Jul | Antibody | UM570009 |
| CD5 | Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 mice. | Journal of proteomics, 2017 Nov | Antibody | TA301354 |
| CD5 | Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas | The American Journal of Pathology, 2016 Jun | Antibody | TA301354 |
| CD5 | T cell receptor rearrangements in a patient with γ-heavy chain disease: A case report | Oncology Letters, 2016 Jun | Antibody | TA501335 |
| CD5 | Role of Fn14 in acute alcoholic steatohepatitis in mice | American Journal of Physiology - Gastrointestinal and Liver Physiology, 2016 Feb | Antibody | TA301354 |
| CD5 | LGR5 is associated with tumor aggressiveness in papillary thyroid cancer | Oncotarget, 2015 Oct | Antibody | TA301354 |
| CD5 | Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway. | Experimental cell research, 2014 May | Antibody | TA301354 |
| CD5 | TWEAK/Fn14 Signaling Is Required for Liver Regeneration after Partial Hepatectomy in Mice | PLoS ONE, 2014 Jan | Antibody | TA301354 |
| CD5 | The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein. | Biochemical and biophysical research communications, 2013 Sep | Antibody | TA301354 |
| CD5 | Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins. | Proteomics, 2012 Nov | Antibody | TA301354 |
| CD51 | αvβ3 integrin expression increases elasticity in human melanoma cells | Biochem. Biophys. Res. Commun., 2020 Mar | Antibody | TA320388 |
| CD55 | Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy | J. Immunol., 2017 Nov | Antibody | SM1141R |
| CD55 | Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy | J. Immunol., 2017 Nov | Antibody | SM1141RT |
| CD55 | Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy | J. Immunol., 2017 Nov | Antibody | SM1141P |
| CD55 | Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy | J. Immunol., 2017 Nov | Antibody | SM1141PS |
| CD55 | Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica | Biochemistry and Biophysics Reports, 2016 May | Antibody | SM1141P |
| CD56 | Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma | Oncol Lett, 2018 Jan | Antibody | TA353710 |
| CD56 | Polysialylation takes place in granulosa cells during apoptotic processes of atretic tertiary follicles | FEBS J., 2015 Sep | Antibody | TA506208S |
| CD56 | Polysialylation takes place in granulosa cells during apoptotic processes of atretic tertiary follicles | FEBS J., 2015 Sep | Antibody | TA506223S |
| CD62E | Canine Angiostrongylus vasorum-Induced Early Innate Immune Reactions Based on NETs Formation and Canine Vascular Endothelial Cell Activation In Vitro | Biology, 2021 May | Antibody | TA318934 |
| CD62P | Canine Angiostrongylus vasorum-Induced Early Innate Immune Reactions Based on NETs Formation and Canine Vascular Endothelial Cell Activation In Vitro | Biology, 2021 May | Antibody | TA318936 |
| CD63 | Formulation and Intracellular Trafficking of Lipid–Drug Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug for Improved Intracellular Delivery to Human Macrophages | ACS Omega, 2020 Feb | Antibody | TA802751 |
| CD63 | Targeting Exosomal EBV-LMP1 Transfer and miR-203 Expression via the NF-κB Pathway: The Therapeutic Role of Aspirin in NPC | Mol Ther Nucleic Acids, 2019 Jun | Antibody | TA802751 |
| CD63 | Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma | Cancer Med, 2019 May | Antibody | TA802751 |
| CD63 | Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis | J Drug Target, 2019 Apr | Antibody | TA802751 |
| CD63 | Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes. | Gastroenterology, 2018 Jul | Antibody | SM3035P |
| CD63 | Modulation of Macrophage Phenotype, Maturation, and Graft Integration through Chondroitin Sulfate Cross-Linking to Decellularized Cornea. | ACS biomaterials science & engineering, 2018 May | Antibody | TA802751 |
Germany
Japan
United Kingdom
China